Bibliography
Found 36 results
Filters: Author is McCutchan, J A [Clear All Filters]
Cortical synaptic density is reduced in mild to moderate human immunodeficiency virus neurocognitive disorder. HNRC Group. HIV Neurobehavioral Research Center. Brain Pathology (Zurich, Switzerland) [Internet]. 1999 ;9(2):209-217. Available from: http://www.ncbi.nlm.nih.gov/pubmed/10219738
. Association between HIV encephalitis, neurodegeneration and neurocognitive dysfunction. In: Journal of Neurovirology. Vol. 6. Journal of Neurovirology. ; 2000. p. 50.
. The relationship between levels of CD4+ counts and HIV-1 RNA in CSF and plasma in 900 samples. In: Eighth Conference on Retroviruses and Opportunistic Infections. Eighth Conference on Retroviruses and Opportunistic Infections. ; 2001.
. Severe, demyelinating leukoencephalopathy in AIDS patients on antiretroviral therapy. AIDS (London, England) [Internet]. 2002 ;16(7):1019-29. Available from: http://www.ncbi.nlm.nih.gov/pubmed/11953468
Patterns of selective neuronal damage in methamphetamine-user AIDS patients. Journal of Acquired Immune Deficiency Syndromes (1999) [Internet]. 2003 ;34(5):467-74. Available from: http://www.ncbi.nlm.nih.gov/pubmed/14657756
. Prediction of incident neurocognitive impairment by plasma HIV RNA and CD4 levels early after HIV seroconversion. Archives of Neurology [Internet]. 2003 ;60(10):1406-12. Available from: http://www.ncbi.nlm.nih.gov/pubmed/14568811
. Correlation of in vivo neuroimaging abnormalities with postmortem human immunodeficiency virus encephalitis and dendritic loss. Archives of Neurology [Internet]. 2004 ;61(3):369-76. Available from: http://www.ncbi.nlm.nih.gov/pubmed/15023814
Enhancing antiretroviral therapy for human immunodeficiency virus cognitive disorders. Annals of Neurology [Internet]. 2004 ;56:416-23. Available from: http://www.ncbi.nlm.nih.gov/pubmed/15349869
. The impact of HIV-associated neuropsychological impairment on everyday functioning. Journal of the International Neuropsychological Society [Internet]. 2004 ;10(3):317-31. Available from: http://www.ncbi.nlm.nih.gov/pubmed/15147590
. Brain mitochondrial injury in human immunodeficiency virus-seropositive (HIV+) individuals taking nucleoside reverse transcriptase inhibitors. Journal of NeuroVirology [Internet]. 2005 ;11(4):356-64. Available from: http://www.ncbi.nlm.nih.gov/pubmed/16206458
Dynamics of monocyte chemoattractant protein type one (MCP-1) and HIV viral load in human cerebrospinal fluid and plasma. Journal of Neuroimmunology [Internet]. 2005 ;169(1-2):144-52. Available from: http://www.ncbi.nlm.nih.gov/pubmed/16182380
. The effects of hepatitis C, HIV, and methamphetamine dependence on neuropsychological performance: biological correlates of disease. AIDS (London, England) [Internet]. 2005 ;19 Suppl 3:S72-8. Available from: http://www.ncbi.nlm.nih.gov/pubmed/16251831
. Genetic composition of human immunodeficiency virus type 1 in cerebrospinal fluid and blood without treatment and during failing antiretroviral therapy. Journal of Virology [Internet]. 2005 ;79(3):1772-88. Available from: http://www.ncbi.nlm.nih.gov/pubmed/15650202
Genetic attributes of cerebrospinal fluid-derived HIV-1 env. Brain: A Journal of Neurology [Internet]. 2006 ;129:1872-83. Available from: http://www.ncbi.nlm.nih.gov/pubmed/16735456
Relationship of antiretroviral treatment to postmortem brain tissue viral load in human immunodeficiency virus-infected patients. Journal of Neurovirology [Internet]. 2006 ;12:100-7. Available from: http://www.ncbi.nlm.nih.gov/pubmed/16798671
. Relationship of CSF leukocytosis to compartmentalized changes in MCP-1/CCL2 in the CSF of HIV-infected patients undergoing interruption of antiretroviral therapy. Journal of Neuroimmunology [Internet]. 2006 ;179:180-5. Available from: http://www.ncbi.nlm.nih.gov/pubmed/16901548
. Low CSF leptin levels are associated with worse learning and memory performance in HIV-infected men. J Neuroimmune Pharmacol. 2007 ;2(4):352-8.
. Association of self-reported painful symptoms with clinical and neurophysiologic signs in HIV-associated sensory neuropathy. Pain. 2010 ;151(3):732-6.
HIV-associated neurocognitive disorders persist in the era of potent antiretroviral therapy: CHARTER Study. Neurology. 2010 ;75(23):2087-96.
Higher HIV-1 genetic diversity is associated with AIDS and neuropsychological impairment. Virology. 2012 ;433(2):498-505.
Role of obesity, metabolic variables, and diabetes in HIV-associated neurocognitive disorder. Neurology. 2012 ;78(7):485-92.
Apolipoprotein E4 genotype does not increase risk of HIV-associated neurocognitive disorders. J Neurovirol. 2013 ;19(2):150-6.
Concurrent classification accuracy of the HIV dementia scale for HIV-associated neurocognitive disorders in the CHARTER Cohort. J Acquir Immune Defic Syndr. 2013 ;62(1):36-42.
Etravirine in CSF is highly protein bound. J Antimicrob Chemother. 2013 ;68(5):1161-8.
Increases in brain white matter abnormalities and subcortical gray matter are linked to CD4 recovery in HIV infection. J Neurovirol. 2013 ;19(4):393-401.